Table 1 Demographics and clinical characteristics of 327 melanoma patients
From: A combination of p300 and Braf expression in the diagnosis and prognosis of melanoma
Variables | Total | Percentage |
|---|---|---|
All melanoma | Â | Â |
Age | Â | Â |
 ≤ 62 | 166 | 50.8% |
 > 62 | 161 | 49.2% |
Gender | Â | Â |
 Male | 196 | 59.9% |
 Female | 131 | 40.1% |
AJCC | Â | Â |
 I | 80 | 24.5% |
 II | 113 | 34.6% |
 III | 55 | 16.8% |
 IV | 79 | 24.2% |
Primary melanoma (n = 193) |  |  |
Age | Â | Â |
 ≤ 62 | 89 | 46.1% |
 > 62 | 104 | 53.9% |
Gender | Â | Â |
 Male | 109 | 56.5% |
 Female | 84 | 43.5% |
Thickness | Â | Â |
 ≤ 2.0 mm | 91 | 47.2% |
 > 2.0 mm | 102 | 52.8% |
Ulceration | Â | Â |
 Absent | 144 | 74.6% |
 Present | 49 | 25.4% |
Metastatic melanoma (n = 134) |  |  |
 Age |  |  |
 ≤ 62 | 77 | 57.5% |
 > 62 | 57 | 42.5% |
Gender | Â | Â |
 Male | 87 | 64.9% |
 Female | 47 | 35.1% |